Partial recovery of adrenal function in a patient with autoimmune Addison's disease.
OBJECTIVE
To our knowledge, no case of remission in autoimmune Addison's disease has previously been reported. We describe a patient with primary adrenal insufficiency caused by autoimmune adrenalitis in whom partial remission was observed after 7 yr.


METHODS
A 39-yr-old male was referred because of extreme fatigue, weight loss, anorexia, nausea, and bouts of fever. During physical examination hyperpigmentation was seen. Laboratory tests showed a plasma cortisol of 0.02 micromol/l (08:30 h). Cortisol failed to increase during the ACTH stimulation test (0.02 to 0.03 micromol/l) and ACTH was markedly elevated (920 pmol/l). Adrenal auto-antibodies were weakly positive. A CT-scan showed no evidence of calcifications or other abnormalities of the adrenal glands. The diagnosis of autoimmune Addison's disease was made and replacement therapy with hydrocortisone and fludrocortisone was started. During the following years the dose of hydrocortisone was gradually decreased. Eventually, the patient decided to stop his medication completely. A repeated ACTH-stimulation test revealed a basal cortisol of 0.25 micromol/l and a peak cortisol of 0.30 micromol/l with a basal ACTH of 178 pmol/l. The patient did not have any complaints.


CONCLUSIONS
Recovery of adrenal insufficiency, due to causes other than autoimmune adrenalitis, has been reported in the past. If our case of partial recovery of autoimmune adrenalitis is not unique this could have profound effects on treatment and follow-up of Addison's disease.
Smans
L C C J
LC
Department of Internal Medicine and Endocrinology, University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands. L.C.C.J.Smans@umcutrecht.nl
Zelissen
P M J
PM
D000224:Addison Disease / Q000097:blood / Q000175:diagnosis / Q000276:immunology*; D000311:Adrenal Glands / Q000276:immunology / Q000502:physiology*; D000324:Adrenocorticotropic Hormone / Q000097:blood; D000328:Adult; D001327:Autoimmune Diseases / Q000097:blood / Q000276:immunology*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood / Q000276:immunology; D008297:Male
D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone
Lancet. 2003 May 31;361(9372):1881-93
12788587
N Engl J Med. 1996 Oct 17;335(16):1206-12
8815944
J Clin Endocrinol Metab. 1993 Apr;76(4):1002-7
8473373
J Assoc Physicians India. 2001 Sep;49:916-7
11837763
N Engl J Med. 1992 Feb 20;326(8):513-8
1732791
Surgery. 2003 Dec;134(6):1020-7; discussion 1027-8
14668736
J Trauma. 2004 May;56(5):1135-7
15179259
Am J Trop Med Hyg. 1993 May;48(5):626-9
8390794
Neuroimmunomodulation. 1994 Jan;1(1):14-22
8528879
J Endocrinol. 1988 Jun;117(3):467-75
3392502
Endocr Pract. 2004 Jan-Feb;10(1):55-61
15251623
J Clin Endocrinol Metab. 1998 Oct;83(10):3507-11
9768655
Arch Intern Med. 1995 Jul 10;155(13):1404-8
7794089
Ann Intern Med. 1991 Nov 15;115(10):785-6
1929027
Neth J Med. 2002 Aug;60(7):269-75
12430572
South Med J. 2003 Sep;96(9):888-90
14513986
Clin Endocrinol (Oxf). 2003 Nov;59(5):593-8
14616882